Syringetin, a flavonoid derivative in grape and wine, induces human osteoblast differentiation through bone morphogenetic protein-2/extracellular signal-regulated kinase 1/2 pathway

Molecular Nutrition and Food Research

Volumn 53, Issue 11, 2009, Pages 1452-1461

  Hsu, Ya Ling ^a   Liang, Hsin Lin ^b,c   Hung, Chih Hsing ^a,d   Kuo, Po Lin ^a,d  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MUNICIPAL UNITED HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; COLLAGEN TYPE 1; FLAVONOID; MITOGEN ACTIVATED PROTEIN KINASE; SMAD PROTEIN; SYRINGETIN;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHEMISTRY; CYTOLOGY; DRUG EFFECT; GRAPE; HUMAN; METABOLISM; OSTEOBLAST; PHYSIOLOGY; SIGNAL TRANSDUCTION; WINE;

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN TYPE I; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLAVONOIDS; HUMANS; MAP KINASE SIGNALING SYSTEM; OSTEOBLASTS; SMAD PROTEINS; VITIS; WINE;

VITACEAE;

EID: 70449572495     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200800483     Document Type: Article

References (41)

1. Ducy, P., Schinke, T., Karsenty, G., The osteoblast: A sophisticated fibroblast under central surveillance. Science 2000,289,1501-1504.
2. Manolagas, S.-C., Jilka, R.-L., Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophy siology of osteoporosis. N. Engl. J. Med. 1995, 332, 305-311.
3. Teitelbaum, S.-L., Bone resorption by osteoclasts. Science 2000,289,1504-1508.
4. Rodan, G.-A., Martin, T.-J., Therapeutic approaches to bone diseases. Science 2000, 289, 1508-1514.
5. Schelonka, E.-P., Usher, A., Ipriflavone and osteoporosis. J. Am. Med. Assoc. 2001, 286, 1836-1837.
6. Berg, C., Neumeyer, K., Kirkpatrick, P., Teriparatide. Nat. Rev. Drug Discov. 2003, 2, 257-258.
7. Lane, N.-E., Kelman, A., A review of anabolic therapies for osteoporosis. Arthritis Res. Ther. 2003, 5, 214-222.
8. Sykaras, N., Opperman, L.-A., Bone morphogenetic proteins (BMPs): how do they function and what can they offer the clinician? J. Oral Sci. 2003, 45, 57-73.
9. Nohe, A., Keating, E., Knaus, P., Petersen, N.-O., Signal transduction of bone morphogenetic protein receptors. Cell Signal 2004, 16, 291-299.
10. Groeneveld, E.-H., Burger, E.-H., Bone morphogenetic proteins in human bone regeneration. Eur. J. Endocrinol. 2000,142,9-21.
11. Jia, T.-L., Wang, H.-Z., Xie, L.-P., Wang, X.-Y., Zhang, R.-Q., Daidzein enhances osteoblast growth that may be mediated by increased bone morphogenetic protein (BMP) production. Biochem. Pharmacol. 2003, 65, 709-715.
12. Friedman, M.-S., Long, M.-W., Hankenson, K.-D., Osteogenic differentiation of human mesenchymal stem cells is regulated by bone morphogenetic protein-6. J. Cell Biochem. 2006, 98, 538-554.
13. Huang, W., Carlsen, B., Wulur, I., Rudkin, G., Ishida, K., Wu, B., Yamaguchi, D. T., Miller, T. A., BMP-2 exerts differential effects on differentiation of rabbit bone marrow stromal cells grown in two-dimensional and three-dimensional systems and is required for in vitro bone formation in a PLGA scaffold. Exp. Cell Res. 2004, 299, 325-334.
14. Lecanda, F., Avioli, L.-V., Cheng, S.-L., Regulation of bone matrix protein expression and induction of differentiation of human osteoblasts and human bone marrow stromal cells by bone morphogenetic protein-2. J. Cell Biochem. 1997, 67,386-396.
15. Takuwa, Y., Ohse, C., Wang, E.-A., Wozney, J.-M., Yamashita, K., Bone morphogenetic protein-2 stimulates alkaline phosphatase activity and collagen synthesis in cultured osteoblastic cells, MC3T3-E1. Biochem. Biophys. Res. Commun. 1991, 174, 96-101.
16. Chang, L., Karin, M., Mammalian MAP kinase signaling cascades. Nature 2001, 410, 37-40.
17. Jadlowiec, J., Koch, H., Zhang, X., Campbell, P.-G., Seyedain, M., Sfeir, C., Phosphophoryn regulates the gene expression and differentiation of NIH3T3, MC3T3-E1, and human mesenchymal stem cells via the integrin/MAPK signaling pathway. J. Biol. Chem. 2004, 279, 53323-53330.
18. Jaiswal, R.-K., Jaiswal, N., Bruder, S.-P., Mbalaviele, G., Marshak, D.-R., Pittenger, M.-F., Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase. J. Biol. Chem. 2000, 275, 9645-9652.
19. Salasznyk, R.-M., Klees, R.-F., Hughlock, M.-K., Plopper, G.-E., ERK signaling pathways regulate the osteogenic differentiation of human mesenchymal stem cells on collagen I and vitronectin. Cell Commun. Adhes. 2004, 11, 137-153.
20. Rodriguez, J.-P., Rios, S., Fernandez, M., Santibanez, J.-F., Differential activation of ERK1,2 MAP kinase signaling pathway in mesenchymal stem cell from control and osteoporotic postmenopausal women. J. Cell Biochem. 2004,92,745-754.
21. Ge, C., Xiao, G., Jiang, D., Franceschi, R.-T., Critical role of the extracellular signal-regulated kinase-MAPK pathway in osteoblast differentiation and skeletal development. J. Cell Biol. 2007, 176, 709-718.
22. [22] Scalbert, A., Williamson, G., Dietary intake and bio availability of polyphenols. J. Nutr. 2000, 130, 2073S-2085S.
23. De Wilde, A., Lieberherr, M., Colin, C., Pointillart, A., A low dose of daidzein acts as an ERbeta-selective agonist in trabecular osteoblasts of young female piglets. J. Cell Physiol. 2004, 200, 253-262.
24. Morris, C., Thorpe, J., Ambrosio, L., Santin, M., The soybean isoflavone genistein induces differentiation of MG63 human osteosarcoma osteoblasts. J. Nutr. 2006, 136, 1166-1170.
25. Prouillet, C., Maziere, J.-C., Maziere, C., Wattel, A., Brazier, M., Kamel, S., Stimulatory effect of naturally occurring flavonols quercetin and kaempferol on alkaline phosphatase activity in MC3T3-E1 human osteoblasts through ERK and estrogen receptor pathway. Biochem. Pharmacol. 2004, 67, 1307-1313.
26. Wu, J.-B., Fong, Y.-C., Tsai, H.-Y., Chen, Y.-F., Tsuzuki, M., Tang, C.- H., Naringin-induced bone morphogenetic protein-2 expression via PI3K, Akt, c-Fos/c-Jun and AP-1 pathway in osteoblasts. Eur. J. Pharmacol. 2008, 588, 333-341.
27. Hsu, Y.-L., Chang, J.-K., Tsai, C.-H., Chien, T.-T., Kuo, P.-L., Myricetin induces human osteoblast differentiation through bone morphogenetic protein-2/p38 mitogen-activated protein kinase pathway. Biochem. Pharmacol. 2007, 73, 504-514.
28. Hsu, Y.-L., Kuo, P.-L., Diosmetin induces human osteoblastic differentiation through the protein kinase C/p38 and extracellular signal-regulated kinase 1/2 pathway. J. Bone Miner. Res. 2008, 23, 949-960.
29. Wang, H., Race, E.-J., Shrikhande, A.-J., Anthocyanin transformation in Cabernet Sauvignon wine during aging. J. Agric. Food Chem. 2003, 51, 7989-7994.
30. Mattivi, F., Guzzon, R., Vrhovsek, U., Stefanini, M., Velasco, R., Metabolite profiling of grape: flavonols and anthocyanins. J. Agric. Food Chem. 2006, 54, 7692-7702.
31. Castillo-Muñoz, N., Gómez-Alonso, S., García-Romero, E., Hermosín-Gutiérrez, I., Flavonol profiles of Vitis vinifera red grapes and their single-cultivar wines. J. Agric. Food Chem. 2007,55,992-1002.
32. Castillo-Muñoz, N., Gómez-Alonso, S., García-Romero, E., Gómez, M.-V., Velders, A.-H., Hermosín-Gutiérrez, I., Flavonol 3-O-glycosides series of Vitis vinifera Cv. Petit Verdot red wine grapes. J. Agric. Food Chem. 2009, 57, 209-219.
33. Reinholz, G.-G., Getz, B., Pederson, L., Sanders, E.-S., Subramaniam, M., Ingle, J.-N., Spelsberg, T.-C., Bispho-sphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts. Cancer Res. 2000, 60, 6001-6007.
34. Kuo, P.-L., Hsu, Y.-L., Chang, C.-H., Chang, J.-K., Osthole-mediated cell differentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway in human osteoblast cells. J. Pharmacol. Exp. Ther. 2005, 314, 1290-1299.
35. Zhu, W., Kim, J., Cheng, C., Rawlins, B. A., Boachie-Adjei, O., Crystal, R.-G., Hidaka, C., Noggin regulation of bone morphogenetic protein (BMP) 2/7 heterodimer activity in vitro. Bone 2006, 39, 61-71.
36. [36] Aubin, J.-E., Liu, F., Malaval, L., Gupta, A.-K., Osteoblast and chondroblast differentiation. Bone 1995, 17, 77S-83S.
37. Qu, Q., Perala-Heape, M., Kapanen, A., Dahllund, J., Salo, J., Vaananen, H.-K., Harkonen, P., Estrogen enhances differentiation of osteoblasts in mouse bone marrow culture. Bone 1998, 22, 201-209.
38. Wada, Y., Kataoka, H., Yokose, S., Ishizuya, T., Miyazono, K., Gao, Y.-H., Shibasaki, Y., Yamaguchi, A., Changes in osteoblast phenotype during differentiation of enzymatically isolated rat calvaria cells. Bone 1998, 22, 479-485.
39. Xiao, Y., Haase, H., Young, W.-G., Bartold, P.-M., Development and transplantation of a mineralized matrix formed by osteoblasts in vitro for bone regeneration. Cell Transplant. 2004,13,15-25.
40. Kuo, P.-L., Huang, Y.-T., Chang, C.-H., Chang, J.-K., Bone morphogenetic protein-2 and -4 (BMP-2 and -4) mediates fraxetin-induced maturation and differentiation in human osteoblast-like cell lines. Biol. Pharm. Bull. 2006, 29, 119-124.
41. Cortizo, A.-M., Lettieri, M.-G., Barrio, D.-A., Mercer, N., Etcheverry, S.-B., McCarthy, A.-D., Advanced glycation end-products (AGEs) induce concerted changes in the osteo-blastic expression of their receptor RAGE and in the activation of extracellular signal-regulated kinases (ERK). Mol. Cell Biochem. 2003, 250, 1-10.